某醫學中心家醫科門診三高病患藥物順應性相關因子分析

Factors Affecting Adherence to Medications for Hypertension, Diabetes Mellitus and Dyslipidemia at Family Medicine Clinic in a Medical Center

10.7023/TJFM.201103.0001

張可臻(Ko-Chen Chang)；周瑩婷(Ying-Ting Chou)；蔡依紋(Yi-Wen Tsai)；羅錦泉(Jiin-Chyuan Luo)；陳昭源(Jau-Yuan Chen)

medication adherence ； hypertension ； diabetes mellitus ； dyslipidemia

台灣家庭醫學雜誌

21卷1期（2011 / 03 / 01）

1 - 14

繁體中文

目的：高血壓、糖尿病（高血糖）、高血脂等三高疾病是基層醫療最常見的慢性病，需要長時間藥物治療以減少心血管疾病之風險。但三高病患的藥物順應性差，因而導致控制率不佳。故本研究計量台灣三高病患的藥物順應性，並找出影響的相關因子，期望對於台灣三高的控制率能有所貢獻。方法：以北部某醫學中心家醫科門診看診，且接受至少三個月藥物治療之三高病患，共140位爲研究對象，填寫結構式問卷和中文版Morisky score量表，其有效問卷爲131份。依照量表區分爲藥物順應性良好和不良兩組，比較兩組閒可能相關因子的差異。結果：有效問卷中，男性80人(61.1%)，女性51人(38.9%)。平均年齡爲56.3±11.7歲。依據Morisky score的計量，高血壓、糖尿病以及高血脂病患有良好藥物順應性比率分別爲35.1%、11.5%、和26.7%。複邏輯回歸分析顯示65歲以上的高血壓與高血脂病患比小於65歲者有較好的藥物順應性，達統計學上之顯著差異；勝算比分別爲3.4及9.7。其餘變項與藥物順應性的相關性則無顯著差異。結論：臨床醫師針對年齡小於65歲之高血壓和高血脂病患，給予加強藥物順應性相關衛教，可能是提高這類病患藥物順應性的良好方式之一。

Purpose: In primary care settings, hypertension, diabetes mellitus, and dyslipidemia are the most common chronic diseases requiring medication control to reduce the risk of cardiovascular events. Patient adherence to these regimens is generally low and this results in poor control of these chronic diseases. The objectives of this study were to measure patients' adherence to these medications and to identify factors associated with medication adherence in family practice.Methods: Data were collected from patients who had hypertension, diabetes mellitus, or dyslipidemia, and received medication for at least 3 months at the Family Medicine Outpatient Department of a medical center in Taiwan. A total of 131 subjects completed a structured questionnaire and the Chinese edition of the Morisky scale to evaluate medication adherence. Subjects were classified as adherent and non-adherent based on a Morisky score of 4 or less than 4, respectively. Multiple logistic regression analysis was used to identify the risk factors for medication non-adherence.Results: Of 131 patients, 98 had hypertension, 46 diabetes mellitus, and 53 dyslipidemia. The average age of the participants was 56.3±11.7 years, and 61% were male. Patients with hypertension, diabetes mellitus, and dyslipidemia had a medication adherence rate of 35.1%, 11.5% and 26.7%, respectively. Based on multivariate analysis, patients aged 65 or older with hypertension or dyslipidemia had a better adherence rate than did younger patients (OR=3.4 and 9.7, respectively). Other factors did not reach statistical significance.Conclusion: To improve patients' adherence, physicians should pay more attention to the education of younger patients (age＜65) with hypertension and dyslipidemia.

1. Sabate E: Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003. Accessed online January 11, 2006, at: http://www.who.int/chronic_conditions/en/adherence_report.pdf.
2. 行政院衛生署中央健保局：健保公布98年藥費前十名藥品。2 0 1 0 / 9 / 1 5 取自：http://www.nhi.gov.tw/information/News_detail.asp?News_ID=834&menu=9&menu _id=544。
3. World Health Organization. Chapter III Hypertension in Adherence to Long-Term Therapies-Evidence for Action. 2003. p. 27. Available: http://www.who.int/chronic_conditions/adherencereport/en/print.html. Accessed August 2005.
4. 內政部，1991、1996、2000、2002，老人狀況調查報告。2010/11/8取自: http://www.stat.gov.tw/public/Data/6741881271.pdf。
5. Almas, A.,Hameed, A.,Ahmed, B.(2006).Compliance to antihypertensive therapy.JCPSP,16,23-6.
6. Andrew, D. Morris(2003).Addressing Dosing Frequency in Diabetes: A Simple Approach to Improving Adherence to Therapy and Clinical Outcomes.Diabetes Educ,29,440-53.
7. Benner, J. S.,Glynn, R. J.,Mogun, H.(2002).Long-term persistence in use of statin therapy in elderly patients.JAMA,288,455-61.
8. Berenson, G. S.,Srinvvaean, S. R.,Bao, W.(1998).Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.N Engl J Med,338,1650-6.
9. Bernard, S. D.(2001).Daily regimen and compliance with treatment.BMJ,323,647.
10. Caro, J. J.,Salas, M.,Speckman, J. L.(1999).Persistence with treatment for hypertension in actual practice.CMAJ,160,31-7.
11. Caspard, H.,Chan, A. K.,Walker, A. M.(2005).Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia.Clin Ther,27,1639-46.
12. Cramer, J. A.(2004).A systematic review of adherence with medications for diabetes.Diabetes Care,27,1218-24.
13. Delamater, A. M.(2006).Improving patient adherence.Clin Diabetes,24,71-7.
14. Fitz-Simon, N.,Bennett, K.,Feely, J.(2005).A review of studies of adherence with antihypertensive drugs using prescription databases.Ther Clin Risk Manag,1,93-106.
15. George, C. F.,Peveler, R. C.,Heiliger, S.(2000).Compliance with tricyclic antidepressants: the value of four different methods of assessment.Br J Clin Pharmacol,50,166-71.
16. Glasgow, R. E.,McCaul, K. D.,Schafer, L. C.(1987).Self-care behaviors and glycemic control in type I diabetes.J Chronic Dis,40,399-412.
17. Grant, R. W.,O''Leary, K. M.,Weilburg, J. B.(2004).Impact of concurrent medication use on statin adherence and refill persistence.Arch Intern Med,164,2343-8.
18. Hashmi, S. K.,Afridi, M. B.,Abbas, K.(2007).Factors associated with adherence to anti-hypertensive treatment in Pakistan.PLoS ONE,2,e280.
19. Hassan, N. B.,Hasanah, C. I.,Foong, K.(2006).Identification of psychosocial factors of noncompliance in hypertensive patients.J Hum Hypertens,20,23-9.
20. Heart Protection Study Collaborative Group(2002).MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial.Lancet,360,7-22.
21. Kim, M. O.,Kim, J. H.,Kim, J. E.(2008).Degree of compliance with polypharmacy and its influential factors in rural elderly patients with chronic diseases in South Korea.J Korean Acad Fam Med,29,604-11.
22. Krapek, K.,King, K.,Warren, S. S.(2004).Medication adherence and associated hemoglobin A1C in type 2 diabetes.Ann Pharmacother,38,1357-62.
23. Krousel-Wood, M.,Thomasa, S.,Muntner, P.,Morisky, D.(2004).Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.Curr Opin Cardiol,19,357-62.
24. Lachaine, J.,Rinfret, S.,Merikle, E. P.(2006).Persistence and adherence to cholesterol lowering agents: evidence from Regie de l'Assurance Maladie duQuebec data.Am Heart J,152,164-9.
25. Lars, Osterberg(2005).Terrence Blaschke: Adherence to Medication.NEJM,353,487-97.
26. Mant, J.,McManus, R. J.(2006).Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control.J Hum Hypertens,20,551-3.
27. Mason, B. L.,Matsuyama, J. R.,Jue, S. G.(1996).Microprocessor-assessed adherence with once- or twice-a-day dosing with Sulfonylurea-no difference.West J Med,164,182.
28. MEInkster, Donnan P. T.,MacDonald, T. M.(2006).Adherence to antihypertensive medication and association with patient and practice factors.J Hum Hypertens,20,295-7.
29. Monane, M.,Bohn, R. L.,Gurwitz, J. H.(1996).A population-based study of compliance with antihypertensive therapy: role of age, gender and race.Am J Public Health,86,1805-9.
30. Morisky, D. E.,Green, L. W.,Levine, D. M.(1986).Concurrent and predictive validity of a self-reported measure of medication adherence.Med Care,24,67-74.
31. Natarajan, N.,Putnam, R. W.,Yip, A. M.,Frail, D.(2007).Family practice patients' adherence to statin medications.Can Fam Physician,53,2144-5.
32. Park, K. A.,Kim, J. G.,Kim, B. W.(2010).Factors that affect medication adherence in elderly patients with diabetes mellitus.Korean Diabetes J,34,55-65.
33. Shepherd, J.,Cobbe, S. M.,Ford, I.(1995).Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.N Engl J Med,333,1301-7.
34. Stratton, I.M.,Adler, A.I.,Neil, H.A.(2000).Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study.BMJ,321,405-12.
35. Sung, J. C.,Nichol, M. B.,Venturini, F.(1998).Factors affecting patient compliance with antihyperlipidemic medications in an HMO population.Am J Manag Care,4,1421-30.
36. Turbi, C.,Herrero-Beaumont, G.,Acebes, J. C.(2004).Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study.Clin Ther,26,245-56.
37. Venturini, F.,Nichol, M. B.,Sung, J. C. Y.(1999).Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study.Ann Pharmacother,33,281-8.
38. Yiannakopoulou, E. Ch.,Papadopulos, J. S.,Cokkinos, D. V.(2005).Adherence to antihypertensive treatment: a critical factor for blood pressure control.Eur J Cardiovasc Prev Rehabil,12,243-9.
39. Youssef, R. M.,Moubarak, I. I.(2002).Patterns and determinants of treatment compliance among hypertensive patients.East Mediterr Health J,8,4-5.
40. 行政院衛生署國民健康局。,未出版
41. 吳祥恩、鄭美玲、盧豐華(1995)。服藥自我報告：簡易高血壓遵醫囑性方法之評估。中華家醫誌，5，84-91。
42. 張云孆(2008)。碩士論文(碩士論文)。國立陽明大學醫務管理研究所。